Evolent Health, Inc.

8-K Shareholder vote results Jun 4, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 10-K Fiscal year ended 2025-12-31 Feb 25, 2026 8-K Results of operations (earnings release) Feb 24, 2026 8-K Other events Dec 8, 2025 8-K Director or officer change; Regulation FD disclosure Dec 2, 2025 10-Q Quarter ended 2025-09-30 Nov 7, 2025 8-K Results of operations (earnings release); Director or officer change Nov 6, 2025 8-K Regulation FD disclosure; Other events Sep 23, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Aug 21, 2025 8-K Other events Aug 19, 2025 8-K Other events Aug 18, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Entered a material agreement; Regulation FD disclosure; Other events Jun 20, 2025 8-K Director or officer change; Shareholder vote results Jun 5, 2025 8-K Regulation FD disclosure Jun 3, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Director or officer change; Regulation FD disclosure Apr 22, 2025 10-K Fiscal year ended 2024-12-31 Feb 21, 2025 8-K Results of operations (earnings release) Feb 20, 2025 8-K Entered a material agreement; Director or officer change; Other events Feb 4, 2025 8-K Took on a direct financial obligation Jan 30, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Entered a material agreement; Took on a direct financial obligation Dec 11, 2024 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Results of operations (earnings release) Nov 7, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Shareholder vote results Jun 11, 2024 8-K Regulation FD disclosure; Other events Jun 4, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024 8-K Results of operations (earnings release) May 9, 2024 10-K Fiscal year ended 2023-12-31 Feb 23, 2024 8-K Results of operations (earnings release) Feb 22, 2024 8-K Director or officer change; Regulation FD disclosure; Other events Feb 14, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jan 8, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Dec 11, 2023